%0 Journal Article
%T Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis
%A Cecilia Amponsem-Boateng
%A Emmanuel Kwateng Drokow
%A Gloria Selorm Akpabla
%A Hafiz Abdul Waqas Ahmed
%A Juanjuan Song
%A Kai Sun
%A Mingyue Shi
%J Archive of "Therapeutics and Clinical Risk Management".
%D 2019
%R 10.2147/TCRM.S203822
%X Purpose: Chimeric Antigen Receptor T(CAR-T) cell therapy is an immunotherapy approach used in treating cancer which has seen rapid development over the decades. It becomes the preferred treatment choice after patients have failed conventional chemotherapy
%K autologous
%K CD19
%K CAR-T
%K hematological malignancies
%K response rate
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511615/